Success Metrics

Clinical Success Rate
75.0%

Based on 9 completed trials

Completion Rate
75%(9/12)
Active Trials
5(17%)
Results Posted
33%(3 trials)
Terminated
3(10%)

Phase Distribution

Ph phase_3
2
7%
Ph not_applicable
7
24%
Ph phase_4
1
3%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

9 of 15 finished

Non-Completion Rate

40.0%

6 ended early

Currently Active

5

trials recruiting

Total Trials

29

all time

Status Distribution
Active(5)
Completed(9)
Terminated(6)
Other(9)

Detailed Status

Completed9
unknown9
Recruiting5
Withdrawn3
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
29
Active
5
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (20.0%)
Phase 41 (10.0%)
N/A7 (70.0%)

Trials by Status

completed931%
recruiting517%
unknown931%
withdrawn310%
terminated310%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT05742321

Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France

Recruiting
NCT05755269

Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

Terminated
NCT03093493

Genetics of Ehlers-Danlos Syndrome

Completed
NCT06534424Not Applicable

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Completed
NCT06354010

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

Recruiting
NCT04655235

Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia

Recruiting
NCT06869486

Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors

Recruiting
NCT05766098

Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY

Recruiting
NCT06023745

Study IL- 35 Level and Fibronectin Type Ⅲ Domain Containing Protein 5 \ Irsin (FNDC5 rs3480) Gene Variations in Chronic Hepatitis B.

Unknown
NCT05907733

Brain-derived Neurotrophic Factor (BDNF) Single Nucleotide Gene Polymorphism and Nerve Growth Factor as Risk Factors That Increase Severity of Allergic Rhinitis

Unknown
NCT05876728

Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer

Unknown
NCT05684406

Mitochondrial DNA Copy Number and Leukocyte Telomere Length as Biomarkers in Type 2 Diabetic Patients

Unknown
NCT05329597

Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer

Unknown
NCT04049786Phase 4

Impact of Bariatric Surgery on Pharmacokinetic Study of Simvastatin and Carvedilol

Unknown
NCT02293096Not Applicable

Pharmacogenetic Prediction of Metoprolol Effectiveness

Terminated
NCT04242420Not Applicable

Connexin Genotypes in Cystic Fibrosis

Unknown
NCT01867203

Functional and Clinical Impact of CYP3A Genetic Polymorphisms on Statin Therapy

Withdrawn
NCT04229823

Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD

Unknown
NCT01930773Phase 3

Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)

Unknown
NCT03554239Not Applicable

Impact of Genotyping P450 2C19 on Hospitalization Period

Withdrawn

Drug Details

Intervention Type
GENETIC
Total Trials
29